Effect of partial pancreatectomy on beta-cell mass in the remnant pancreas of Wistar fatty rats.
Wistar fatty rat, which has been established by transferring the fa gene of Zucker fatty rat to the Wistar Kyoto rat, has many features in common with human NIDDM. It exhibits hyperglycemic obesity with hyperinsulinemia and insulin resistance. It is unclear, however, whether a defect in the beta-cell proliferation is related to the onset of diabetes mellitus together with insulin resistance in this model rat. To determine this, we compared non-fasting plasma glucose levels, insulin content and beta-cell mass in the remnant pancreas of Wistar fatty rats with those in their diabetic-resistant lean counterparts after a 70% partial pancreatectomy. We also examined whether such a defect, if present, could be improved by either phlorizin or nicotinamide. We further investigated if there were any differences in these parameters between the phenotypically identical but genotypically different Wistar lean rats with a gene type of homogeneous Fa/Fa and that of heterogeneous Fa/fa. Male rats, 6 weeks of age, were allocated at random into two groups: 70% pancreatectomy (Px) and sham-pancreatectomy (sham). A sustained hyperglycemia was evident in the Px Wistar fatty rats after surgery, which was accompanied by a reduction of insulin content and beta-cell mass in the remnant pancreas. The changes in insulin content and beta-cell mass were unaffected by restoration of normoglycemia, induced by phlorizin injection. The administration of nicotinamide partially ameliorated the sustained hyperglycemia by a slight but not significant increase in beta-cell mass. No discernible difference in the above parameters was observed between the Wistar lean rats with Fa/Fa and those with Fa/fa. These findings suggest that Wistar fatty rats have a poor capacity for proliferation of pancreatic beta-cells, which causes the onset of overt diabetes along with insulin resistance due to extreme obesity.
Ogino
T
T
Department of Laboratory Medicine, University of Tokushima School of Medicine, Japan.
Zhu
M
M
Murakami
T
T
Kuwajima
M
M
Shima
K
K
D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D002455:Cell Division; D003920:Diabetes Mellitus / Q000235:genetics / Q000473:pathology; D003924:Diabetes Mellitus, Type 2 / Q000473:pathology* / Q000601:surgery; D004195:Disease Models, Animal; D005838:Genotype; D006943:Hyperglycemia / Q000209:etiology; D007328:Insulin / Q000032:analysis; D007333:Insulin Resistance; D007515:Islets of Langerhans / Q000473:pathology*; D008297:Male; D009536:Niacinamide / Q000627:therapeutic use; D009765:Obesity; D010180:Pancreatectomy / Q000379:methods*; D010641:Phenotype; D010695:Phlorhizin / Q000627:therapeutic use; D051381:Rats; D011921:Rats, Inbred WKY; D011922:Rats, Mutant Strains / Q000033:anatomy & histology*; D017208:Rats, Wistar; D011924:Rats, Zucker / Q000235:genetics
D001786:Blood Glucose; D007328:Insulin; D009536:Niacinamide; D010695:Phlorhizin